Zentalis Pharmaceuticals, Inc.
ZNTL
$2.76
$0.093.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.74% | -28.26% | -28.84% | -32.01% | -23.16% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.89% | -15.67% | -38.29% | -29.64% | -27.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.42% | -27.97% | -29.12% | -31.94% | -22.28% |
|
|
|||||
| Total Current Assets | -34.42% | -27.97% | -29.12% | -31.94% | -22.28% |
| Net Property, Plant & Equipment | -21.99% | -13.81% | -11.72% | -12.95% | -10.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.39% | -29.18% | -38.54% | -37.40% | -25.84% |
| Total Assets | -32.85% | -27.38% | -28.47% | -31.11% | -22.00% |
|
|
|||||
| Total Accounts Payable | -3.09% | -14.28% | -81.81% | -26.02% | -50.17% |
| Total Accrued Expenses | -40.11% | -40.78% | -27.70% | -7.29% | -18.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.07% | 33.46% | 33.89% | 28.11% | 17.12% |
| Total Finance Division Other Current Liabilities | -- | 228.95% | 17.65% | -- | -- |
| Total Other Current Liabilities | -- | 228.95% | 17.65% | -- | -- |
| Total Current Liabilities | -30.66% | -32.27% | -41.49% | -9.80% | -23.99% |
|
|
|||||
| Total Current Liabilities | -30.66% | -32.27% | -41.49% | -9.80% | -23.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.79% | -9.27% | -8.78% | -9.30% | -8.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -41.11% | -49.80% | -54.09% | -56.88% | -52.30% |
| Total Liabilities | -21.89% | -22.79% | -29.23% | -10.20% | -18.50% |
|
|
|||||
| Common Stock & APIC | 1.18% | 3.62% | 4.06% | 4.58% | 5.09% |
| Retained Earnings | -13.00% | -14.83% | -16.84% | -25.52% | -18.66% |
| Treasury Stock & Other | -64.87% | -88.33% | -57.86% | -53.69% | -74.57% |
| Total Common Equity | -35.88% | -28.63% | -28.25% | -35.61% | -22.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.88% | -28.63% | -28.25% | -35.61% | -22.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.88% | -28.63% | -28.25% | -35.61% | -22.91% |
|
|
|||||